Alaria esculenta, Ulva lactuca, and Palmaria palmata as Potential Functional Food Ingredients for the Management of Metabolic Syndrome.

Shannon, Emer et al.·Foods (Basel·2025·Preliminary Evidencelaboratory study (in vitro)
RPEP-13543Laboratory study (in vitro)Preliminary Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
laboratory study (in vitro)
Evidence
Preliminary Evidence
Sample
N=Not applicable (in vitro study)
Participants
Three seaweed species tested against metabolic syndrome enzymes

What This Study Found

Seaweed extracts matched or exceeded the enzyme-inhibiting activity of prescription drugs: Palmaria palmata peptides matched captopril for ACE-1 inhibition, and Alaria esculenta polyphenols outperformed both acarbose and orlistat for alpha-amylase and lipase inhibition.

Key Numbers

P. palmata peptides ACE-1 IC50: 94.29 mcg/mL (vs captopril 91.83). A. esculenta polyphenols alpha-amylase IC50: 147.04 (vs acarbose 185.67). A. esculenta lipase IC50: 106.21 (vs orlistat 139.74). U. lactuca polysaccharides alpha-amylase IC50: 168.06 (vs acarbose 185.67).

How They Did This

In vitro enzyme inhibitory assays for ACE-1, alpha-amylase, and lipase. Compared seaweed extracts (peptides, polyphenols, polysaccharides) to reference drugs. Proximate analysis of protein, fiber, and fatty acid content.

Why This Research Matters

Metabolic syndrome (high blood pressure, diabetes, obesity) affects millions. Natural seaweed-derived alternatives could provide dietary approaches to managing these conditions with fewer side effects.

What This Study Doesn't Tell Us

In vitro assay only. Enzyme inhibition in a test tube does not guarantee in vivo efficacy. Bioavailability after oral consumption unknown. Seaweed composition varies by season and location.

Trust & Context

Original Title:
Alaria esculenta, Ulva lactuca, and Palmaria palmata as Potential Functional Food Ingredients for the Management of Metabolic Syndrome.
Published In:
Foods (Basel, Switzerland), 14(2) (2025)
Database ID:
RPEP-13543

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Cite This Study

RPEP-13543·https://rethinkpeptides.com/research/RPEP-13543

APA

Shannon, Emer; Hayes, Maria. (2025). Alaria esculenta, Ulva lactuca, and Palmaria palmata as Potential Functional Food Ingredients for the Management of Metabolic Syndrome.. Foods (Basel, Switzerland), 14(2). https://doi.org/10.3390/foods14020284

MLA

Shannon, Emer, et al. "Alaria esculenta, Ulva lactuca, and Palmaria palmata as Potential Functional Food Ingredients for the Management of Metabolic Syndrome.." Foods (Basel, 2025. https://doi.org/10.3390/foods14020284

RethinkPeptides

RethinkPeptides Research Database. "Alaria esculenta, Ulva lactuca, and Palmaria palmata as Pote..." RPEP-13543. Retrieved from https://rethinkpeptides.com/research/shannon-2025-alaria-esculenta-ulva-lactuca

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.